How should hip osteoarthritis be managed non‑surgically?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 9, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Hip Osteoarthritis

Begin immediately with the triad of structured exercise programs, patient education, and weight loss (if overweight/obese), supplemented by topical NSAIDs for initial pain control, as this combination addresses both symptom relief and disease modification. 1, 2, 3

Core Non-Pharmacological Interventions (Start These First)

Structured Exercise Programs

  • Implement land-based strengthening, aerobic exercise, and aquatic therapy as the foundation of all treatment plans 1, 2, 4
  • Prescribe a minimum of 12 supervised physical therapy sessions, as this demonstrates superior outcomes compared to fewer sessions 3
  • Exercise reduces pain, improves function, and addresses the bilateral muscle weakness and atrophy characteristic of hip OA (affecting hip flexors, extensors, abductors, knee flexors/extensors, gluteus maximus, gluteus minimus, hamstrings, quadriceps, and adductors) 5
  • Continue exercise indefinitely even after symptom improvement to prevent progression 2

Weight Loss (Mandatory for BMI ≥25)

  • Target structured weight reduction of 4-7 kg through weekly supervised sessions 3
  • Weight loss improves pain, physical function, mobility, and quality of life by reducing cumulative joint loading 1, 2
  • Evidence for hip OA weight loss benefits is more limited than for knee OA, but the intervention remains recommended 1

Patient Education

  • Provide structured education about disease process, prognosis, and treatment expectations to improve self-efficacy and adherence 2
  • Implement formal self-management programs teaching symptom monitoring and activity adjustment 2

Assistive Devices

  • Prescribe canes when disease impacts ambulation 3

Pharmacological Management (Sequential Approach)

First-Line: Topical Agents

  • Insufficient evidence exists for topical NSAIDs specifically for hip OA (evidence is strong for knee OA only) 1
  • Insufficient evidence for topical capsaicin for hip OA 1

Second-Line: Oral Medications

  • Offer acetaminophen and/or oral NSAIDs (such as naproxen 500 mg twice daily or celecoxib 100-200 mg daily) for hip pain 1, 3, 6, 7
  • Oral NSAIDs demonstrate superiority to acetaminophen in moderate-to-severe OA pain 3
  • Celecoxib 100 mg twice daily or 200 mg once daily provides equivalent effectiveness for OA 6
  • Naproxen causes statistically significantly less gastric bleeding than aspirin 7

Third-Line: Duloxetine

  • Add duloxetine 60 mg daily as alternative or adjunctive therapy when acetaminophen/NSAIDs are inadequate or contraindicated 1, 3, 8
  • Provides significant reductions in pain and improvements in physical function 3

Avoid Opioids

  • Do not initiate opioids (including tramadol) for hip OA pain 1, 3
  • For patients already on long-term opioids, refer to opioid management guidelines 1
  • Tramadol may provide short-term pain relief but is not recommended for initiation 9

Intra-Articular Injections

Corticosteroid Injections

  • Offer intra-articular corticosteroid injections for persistent hip pain inadequately relieved by oral medications and physical therapy 1, 3, 9
  • Hip injections require image guidance (unlike knee injections) 3
  • Avoid injections within 3 months preceding joint replacement surgery 3
  • Provides short-term pain relief 8

Hyaluronic Acid (Viscosupplementation)

  • Most societies recommend against viscosupplementation for hip OA 9

Platelet-Rich Plasma

  • Has potential benefits but evidence of effectiveness remains incomplete 9

Avoid These Interventions

  • Do not use glucosamine 9
  • Do not routinely obtain MRI for diagnosis (plain radiographs with weight-bearing views are sufficient) 1
  • Do not use typical opioids 9

Treatment Sequencing Algorithm

  1. Initiate immediately: Education + structured exercise (minimum 12 supervised sessions) + weight loss if BMI ≥25 2, 3

  2. Add at 0-2 weeks: Oral NSAIDs or acetaminophen for symptomatic relief 3

  3. If inadequate response after 4-6 weeks: Add duloxetine OR intra-articular corticosteroid injection (image-guided) 3

  4. Reassess every 4-6 weeks during initial treatment phase 2

Surgical Referral Criteria

Consider surgical consultation when:

  • End-stage OA with minimal/no joint space on weight-bearing radiographs 3
  • Inability to cope with pain after exhausting all appropriate conservative options 3
  • Obtain weight-bearing plain radiographs before surgical referral 3

Evidence for Surgery vs. Conservative Treatment

  • Total hip replacement results in clinically important, superior reduction in hip pain (mean Oxford Hip Score improvement of 15.9 points vs. 4.5 points with resistance training at 6 months, difference 11.4 points, P<0.001) in patients ≥50 years with severe hip OA and surgical indication 10
  • At 6 months, 21% of patients assigned to resistance training crossed over to total hip replacement 10

Complementary Interventions

Mind-Body Therapies

  • Tai chi is strongly recommended for hip OA, combining meditation with gentle movements, breathing exercises, and relaxation 3
  • Insufficient evidence for yoga specifically for hip OA (evidence exists for knee OA only) 3
  • Cognitive behavioral therapy may reduce pain and improve coping 3

Other Modalities

  • Insufficient evidence for acupuncture, massage, or transcutaneous electrical nerve stimulation for hip OA 1

Critical Pitfalls to Avoid

  • Do not delay core interventions (exercise, weight loss, education) while pursuing pharmacological management—these must start simultaneously 2
  • Do not perform hip injections without image guidance—unlike knee injections, hip anatomy requires imaging 3
  • Do not continue ineffective treatments—reassess every 4-6 weeks and escalate therapy 2
  • Do not use MRI routinely for diagnosis—it adds no diagnostic value over plain radiographs for OA 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Non-Surgical Management of Knee Osteoarthritis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Hip and Knee Pain

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hip Pain and Mobility Deficits-Hip Osteoarthritis: Revision 2025.

The Journal of orthopaedic and sports physical therapy, 2025

Research

Non-operative Treatment Options for Osteoarthritis in the Hip.

HSS journal : the musculoskeletal journal of Hospital for Special Surgery, 2023

Related Questions

What conservative treatments are available for a patient with hip osteoarthritis to manage pain?
What are the initial treatment recommendations for patients with arthritis (Arthritis) or osteoarthritis (Osteoarthritis)?
What pain management options are available for a 93-year-old patient with an arthritic knee, unable to bear weight, and on anticoagulant (blood thinner) therapy for Atrial Fibrillation (AFib) with a pacemaker?
What follow-up and treatment are needed for a 30-year-old female with hip and knee pain, hip X-ray showing tiny labral (labrum-related) ossifications, and knee X-ray showing osteophytes (bone spurs), considering possible diagnoses such as osteoarthritis or rheumatoid arthritis?
What is the diagnosis and recommended follow-up for a 63-year-old male presenting with left hip pain and radiographic evidence of osteoarthritis (OA) changes on hip X-ray, with no displaced fractures observed?
In a patient with acute‑on‑chronic liver failure, multi‑organ failure and renal dysfunction (or on renal replacement therapy) at high risk for hyperphosphatemia, which phosphate binder regimen should be started?
What are the standard dosing regimens of octreotide and terlipressin for an adult patient with chronic liver disease presenting with an acute upper gastrointestinal (variceal) bleed?
A patient with drug‑sensitive tuberculosis started on isoniazid, rifampicin, pyrazinamide, and ethambutol develops clinical jaundice with liver enzymes less than twice the upper limit of normal; how should the anti‑TB regimen be managed?
What are the differential diagnoses for a patient with left submandibular lymphadenopathy lasting two weeks after repeated choking blows in jujitsu, with an otherwise normal examination?
Can tigecycline be used to treat a methicillin‑resistant Staphylococcus aureus (MRSA) skin or soft‑tissue abscess in a child?
In an adult with newly diagnosed type 2 diabetes mellitus, how can fasting blood glucose levels be used to decide between monotherapy, dual oral therapy, triple oral therapy, or insulin initiation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.